Nebiyou Yonas Metaferia - Publications
Affiliations: | Dana-Farber Cancer Institute, Boston, MA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2022 | Tang S, Sethunath V, Metaferia NY, Nogueira MF, Gallant DS, Garner ER, Lairson LA, Penney CM, Li J, Gelbard MK, Alaiwi SA, Seo JH, Hwang JH, Strathdee CA, Baca SC, et al. A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer. Cell Reports. 38: 110417. PMID 35196489 DOI: 10.1016/j.celrep.2022.110417 | 0.35 | |||
2022 | Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, Braun DA, Hirsch L, Steinharter JA, Bouchard G, Walton E, et al. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Reports. 38: 110190. PMID 34986355 DOI: 10.1016/j.celrep.2021.110190 | 0.35 | |||
Show low-probability matches. |